US OptionsDetailed Quotes
WST240517P330000
- 2.17
- 0.000.00%
15min DelayTrading May 17 09:59 ET
0.00High0.00Low
0.00Open2.17Pre Close0 Volume1 Open Interest330.00Strike Price0.00Turnover910.34%IV-5.04%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry2.17Time Value100Contract SizeAmericanOptions Type-0.1510Delta0.0088Gamma159.09Leverage Ratio-125.5828Theta0.0000Rho-24.03Eff Leverage0.0069Vega
West Pharmaceutical Services Stock Discussion
Sign in to post a comment
RECAP
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average(.DJI.US$ up 0.91% to 38,664. The $Nasdaq Composite Index(.IXIC.US$ was moderately higher at 15,906, af...
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average(.DJI.US$ up 0.91% to 38,664. The $Nasdaq Composite Index(.IXIC.US$ was moderately higher at 15,906, af...
41
5
Analysts worry about the company's shifting tone and the enduring effect of clients' inventory management on West's finances. Doubts also arise about the company's demand visibility and if current trends suggest a fundamental issue in West's base business.
Jefferies analyst David Windley sees FDA approvals of GLP-1s for obesity treatment as a huge opportunity for the manufacturing supply chain. He also notes high rivalry in the injectable fill/finish market. Windley upgraded West Pharmaceutical to Buy, raising its price target by 66% to $536, citing its global footprint and capacity to meet growing GLP-1s demand.
The market sentiment around West Pharmaceutical Services hasn't changed much over the past five years, with the share price seemingly reacting to the EPS. The recent improvement in TSR could indicate that the business is getting better with time.
1
The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.
1
1. $Apple(AAPL.US$ : +59,918% (20 year total return)
2. $Monster Beverage(MNST.US$ : +59,299%
3. $NVIDIA(NVDA.US$ : +28,712%
4. $Intuitive Machines(LUNR.US$: +18,221%
5. $Booking Holdings(BKNG.US$ : +16,299%
6. $Netflix(NFLX.US$ : +13,442%
7. $Old Dominion Freight Line(ODFL.US$ : +9,403%
8. $SBA Communications Corp(SBAC.US$ : +7,356%
9. $Copart(CPRT.US$ : +6,592%
10. $Regeneron Pharmaceuticals(REGN.US$ : +6,296%
11. $Amazon(AMZN.US$ ...
2. $Monster Beverage(MNST.US$ : +59,299%
3. $NVIDIA(NVDA.US$ : +28,712%
4. $Intuitive Machines(LUNR.US$: +18,221%
5. $Booking Holdings(BKNG.US$ : +16,299%
6. $Netflix(NFLX.US$ : +13,442%
7. $Old Dominion Freight Line(ODFL.US$ : +9,403%
8. $SBA Communications Corp(SBAC.US$ : +7,356%
9. $Copart(CPRT.US$ : +6,592%
10. $Regeneron Pharmaceuticals(REGN.US$ : +6,296%
11. $Amazon(AMZN.US$ ...
7
2
There's a gap between West Pharmaceutical Services' high P/E ratio and its forecasted market-matching growth. Investors appear more bullish than analysts, but this earnings growth level could impact share price, making the high share price difficult to justify.
West Pharmaceutical Services, with its surplus and larger cash amount than debt, has a conservative balance sheet, indicating an ability to easily eliminate debt. With a free cash flow being 53% of EBIT, the company is in a strong position to pay down debt when needed.
West Pharmaceutical Services' stock shows promising performance and price momentum. Stable market sentiment and improvements in one-year TSR indicate recent performance enhancement.
W...
9
No comment yet
Qulynnitha Bowman : How much money do i need to invest in stocks
102556055 : $Futu Holdings Ltd (FUTU.US)$
Cypher : “$Microsoft(MSFT.US)$'s OpenAi released a short 60-minute video.”
The video is 60 seconds, not minutes. The writing quality on this platform has really been down lately. I’ve caught way too many errors.
bellalita : good news
Malik ritduan : oo